Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
RIGL

Market Cap: $874.04M

RI

Rigel Pharmaceuticals, Inc.

RIGL

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin91.39%

EBITDA Margin33.97%

EBIT Margin33.02%

Pre-tax Margin30.92%

Net Profit Margin1.16%

Earnings Yield36.75%

Valuation Multiples

Price / Book2.06

Price / Sales3.16

Price / Earnings2.67

PEG0.01

Forward PEG0.08

EV / Sales3.08

EV / EBITDA9.07

EV / Operating Cash Flow10.75

EV / Free Cash Flow10.75

Price / Free Cash Flow11.01

Price / Operating Cash Flow11.03

Cash Flow & Capital

Free Cash Flow / Share$4.28

Operating Cash Flow / Share$4.28

Free Cash Flow Yield9.08%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue5.93%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.95

Quick Ratio1.79

Cash Ratio0.64

Debt / Assets0.08

Debt / Capital0.09

Debt / Equity0.09

Long-Term Debt / Capital0.00

Debt / Market Cap4.49%

Net Debt / EBITDA-0.22

Solvency Ratio3.40

Financial Leverage1.22

Efficiency & Working Capital

Asset Turnover0.53

Fixed Asset Turnover427.80

Inventory Turnover1.66

Receivables Turnover4.94

Payables Turnover5.94

Days Sales Outstanding73.9

Days Inventory Outstanding219.97

Days Payables Outstanding61.41

Operating Cycle293.88

Cash Conversion Cycle232.46

Working Capital Turnover2.36

Returns & Quality

Return on Equity96.49%

Return on Assets61.78%

Return on Invested Capital18.70%

ROCE20.45%

Return on Tangible Assets75.36%

Operating Return on Assets16.97%

Income Quality0.25

Tax Burden3.76

Interest Burden0.94

Balance Sheet & Intrinsic Metrics

Enterprise Value$853.17M

Invested Capital$184.7M

Working Capital$90.17M

Tangible Asset Value$331.77M

Net Current Asset Value$90.11M

Graham Number$94.67

Graham Net-Net$2.65

Book Value / Share$22.96

Tangible Book Value / Share$17.89

Cash / Share$5.14

Financial Health Scores

Piotroski Score4

Altman Z-Score4.14

Revenue$276.79M

EBIT$91.38M

Market Cap$874.78M

Working Capital$90.17M

Retained Earnings$-997.1M

Total Assets$521.07M

Total Liabilities$95.42M